Gut microbiota-dependent marker TMAO in promoting cardiovascular disease: inflammation mechanism, clinical prognostic, and potential as a therapeutic target

S Yang, X Li, F Yang, R Zhao, X Pan, J Liang… - Frontiers in …, 2019 - frontiersin.org
Cardiovascular disease (CVD) is the leading cause of death worldwide, especially in
developed countries, and atherosclerosis (AS) is the common pathological basis of many …

Management of measurable variable cardiovascular disease'risk factors

S Francula-Zaninovic, IA Nola - Current cardiology reviews, 2018 - ingentaconnect.com
Aim: To summarize the main findings on variable cardiovascular risk factors and their
management in everyday practice. Methods: A narrative review of the relevant literature …

COVID-19 future forecasting using supervised machine learning models

F Rustam, AA Reshi, A Mehmood, S Ullah… - IEEE …, 2020 - ieeexplore.ieee.org
Machine learning (ML) based forecasting mechanisms have proved their significance to
anticipate in perioperative outcomes to improve the decision making on the future course of …

Calculating the sample size required for developing a clinical prediction model

RD Riley, J Ensor, KIE Snell, FE Harrell, GP Martin… - Bmj, 2020 - bmj.com
Clinical prediction models aim to predict outcomes in individuals, to inform diagnosis or
prognosis in healthcare. Hundreds of prediction models are published in the medical …

Minimum sample size for developing a multivariable prediction model: PART II‐binary and time‐to‐event outcomes

RD Riley, KIE Snell, J Ensor, DL Burke… - Statistics in …, 2019 - Wiley Online Library
When designing a study to develop a new prediction model with binary or time‐to‐event
outcomes, researchers should ensure their sample size is adequate in terms of the number …

[PDF][PDF] 2016 European Guidelines on cardiovascular disease prevention in clinical practice

MF Piepoli, AW Hoes, S Agewall… - Polish Heart …, 2016 - journals.viamedica.pl
2.3. 9. Wnioski................................................ 838 2.4. Inne markery ryzyka.......................................
. 840 2.4. 1. Wywiad rodzinny/(epi) genetyka............ 840 2.4. 1.1. Wywiad …

Deep learning approach for diabetes prediction using PIMA Indian dataset

H Naz, S Ahuja - Journal of Diabetes & Metabolic Disorders, 2020 - Springer
Abstract Purpose International Diabetes Federation (IDF) stated that 382 million people are
living with diabetes worldwide. Over the last few years, the impact of diabetes has been …

Prediction models for cardiovascular disease risk in the general population: systematic review

JAAG Damen, L Hooft, E Schuit, TPA Debray… - bmj, 2016 - bmj.com
Objective To provide an overview of prediction models for risk of cardiovascular disease
(CVD) in the general population. Design Systematic review. Data sources Medline and …

Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration

KGM Moons, DG Altman, JB Reitsma… - Annals of internal …, 2015 - acpjournals.org
The TRIPOD (Transparent Reporting of a multivariable prediction model for Individual
Prognosis Or Diagnosis) Statement includes a 22-item checklist, which aims to improve the …

Bariatric–metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre …

G Mingrone, S Panunzi, A De Gaetano, C Guidone… - The Lancet, 2015 - thelancet.com
Background Randomised controlled trials have shown that bariatric surgery is more effective
than conventional treatment for the short-term control of type-2 diabetes. However …